TRANSCRIPT

Q3 2026 — Sellside analyst results transcript

Q3 2026PDF · 17 pages199 KB
Investor Relations
1
Barclays PLC Q3 2026 Results
10 November 2026
Analyst Sell Side Meeting transcript
(amended in places to improve accuracy and readability)
Anna Cross, Group Finance Director
Good afternoon everyone, and thank you for joining. Before we start, I just want to introduce a couple
of people. The first is Andrew Dickens sitting to my left, who is our interim Group Treasurer. I'm sure
you'll have the opportunity to interact with Andrew over the coming quarters. And then at the same
time, recognising that Marina is going off to pastures new, as you will know, she's going off to be
Venkat’s Chief of Staff. And so taking up her role we have Mathias Peters, who many of you will know
from the Equity Sales side of the firm. So hopefully you will get to know my new colleagues [in the
following] quarters.
Let me start with some of the themes from our conversations with investors on the road and indeed
with many of you since results.
First, on costs. Whilst the clarity on the path to around £18.4 billion in 2027 has been welcomed,
naturally focus has turned to 2028. To be clear, our guidance of modest cost growth is from 2025 to
2028. And the bridge we laid out at Q3 provides a good framework to think about 2028, distinguishing
between running the bank and investing in the future.
First, is that our aim is to contain run-the-bank costs in 2027 through efficiency savings offsetting
business growth and inflation. And second, we have laid out a path which accelerates planned
investments in 2027.
Given that our north star is the cost income ratio, we retain flexibility in our cost base to support this,
primarily through the business growth bucket. We called out £0.6bn of business growth in 2027 which
includes performance costs and other spend which we can flex.
Looking nearer term, we confirmed that structural cost actions in Q4 will be around £300 million. When
thinking about the divisional allocation of that, you should expect the split to be broadly in alignment
with their share of Group costs. The one piece that I would call out is that we are continuing to invest
to drive additional scale in UK Wealth within Private Banking and Wealth Management. These
investments increased costs by 7% in Q3, and we continue to expect a similar increase in Q4.
The next point will be clarity on Bank taxes following the UK Budget, let me outline how we expect this
to be reflected in the financial statements. The announced 3% increase in the UK banking surcharge
will apply for 15 months from January 2027. Consistent with the sensitivity we gave you previously,
we expect this to add around £100 million to the tax charge in 2027 and around £25 million in 2028.
In addition to that, we now expect an increase in the value of the UK Deferred Tax Assets (DTAs),
which will provide an offsetting tax benefit of around £75 million in Q426, when the change is passed
into law.

-- 1 of 17 --

Investor Relations
2
So, to understand the overall impact, you need to consider both effects. When calculating your
effective tax rate in Q4 this year, in addition to the DTA revaluation benefit, I would also remind you
that our annual bank levy is not tax deductible. We would expect the effective tax rate in Q4 to be
higher than the Q3 YTD.
Finally, we recognise that the outlook on retail margins remains in focus. NII has not reached a ceiling
in 2026, and we expect continued momentum into next year. As I stand here today, emerging
consensus for 2027 Group and BUK NII looks broadly in the right place. But don’t expect us to mark-
to-market this that frequently as consensus is always moving.
We feel that our experience is differentiated to peers in at least two areas. First, the Group is broader
than just Barclays UK, with momentum expected across all divisions. Second, we remain well
positioned to manage deposit margin dynamics.
This is supported by our strong funding position reflected in both our BUK customer Loan to Deposit
Ratio [LDR] of 92%, and our Liquidity Coverage Ratio [LCR] in the ring-fenced bank of 158%. Within
Barclays UK, the building blocks for NII remain unchanged. The benefit from the structural hedge and
lending growth will be partly offset by deposit margin dynamics.
In the near term, as I said at Q3 results, we expect the product margin bucket to be negative in Q4.
This is due to a structural hedge top up in early October which increases hedge income but reduces
product margin with no material net effect.
With that, I’m happy to take your questions. As ever, please give your name first, as this session is
being transcribed.
Phil Richards, Bloomberg Intelligence
Phil Richards at Bloomberg Intelligence. Two questions. First one is on the 2028 RoTE target of over
14%. Consensus is different now, about 15%. So I guess we're trying to work out if the market is
getting a bit too carried away with itself or do you think you've been too conservative? That's the first
one. And then the second is just I guess more longer term looking at the Investment Bank overall. The
RoTE over the last 12 months, 11%, is very low versus the rest of the divisions, of course now it's been
the case for some time and I'm just [wondering] how you look at that in a broader view.
Anna Cross
Okay. So on the first, look, we've given you a target for 2028. That target is greater than 14%. So our
targets are not capped and that reflects both our investment in the business and our ambition for
the businesses. I'm not going to comment on consensus RoTE, but just to remind you that they are
uncapped RoTE targets that we've given you.
The second question, [the Investment Bank] run rates over the last 12 months, roughly 11%, we
remain very focused on reaching 12% for the current year. And our objective in the first stage of the
plan and indeed in this stage has been to materially improve the RoTE of the Investment Bank on a
structural basis. So in 2023, the RoTE of the Investment Bank was 7%. So over the last few years, we
now expect that to have moved by five percentage points. Through all of the actions that we've been

-- 2 of 17 --

Investor Relations
3
taking and they remain in place, remain very much our focus: diversification of income, greater
stability of income.
You can see consistent delivery of positive jaws within that business and good capital discipline. So all
of those things remain and we're happy with its progress.
Thank you. Chris?
Chris Hallam, Goldman Sachs
Chris Hallam from Goldman Sachs. So two questions. First on data centres, I'm sure you saw the
headline today from the PRA about thinking about exposure across UK banks. Just any data points or
commentary you'd like to provide us on your data centre exposure and how you think about managing
that risk. And then secondly, again on lending margins. So lending margins let's say have been
competed down to relatively low levels in recent years in the UK. Clearly there's high demand for
lending now. Are you seeing in the fourth quarter or as you look into next year, any kind of green shoots
on lending margin that we should maybe think about in the context of the deposit margin dynamics
which maybe the lending margin dynamics come later than the deposit margin headwinds?
Anna Cross
Okay. Thanks Chris. So on data centres, our exposure to an appetite for data centres has not
materially changed over the last year. As we've been on the road, we've been discussing with people
our exposure or our commitment to data centres, not drawn, but commitment is around £4.5 billion.
That is flat year on year. So that's not the drawn amount. That's split roughly half and half between
corporate exposure and exposure that would be sitting within our structured finance book within
Markets and would have all of the associated benefits that you would expect from that: margining,
rapid turnover, et cetera, et cetera. So it's fairly limited in terms of our exposure and as I say, not
materially changed. And one of the things that we have also talked about on the road is our experience
in Leveraged Finance. You will have seen that our results in Leveraged Finance have been somewhat
lower than we've come to expect in terms of market share.
That is a direct reflection of how we see risk and return in that particular part of the market.
So that's your first one. On your second one on lending margins, look, we would expect there to be
some correlation between lending margins and liability margins. And I spoke on the call about the fact
that funding costs in the UK are going up and therefore to maintain margins across the sort of broader
system, you would expect there to be some relief in lending margins. Fair to say we have not seen that
yet. For our own part, we've obviously had some wider margin lending rolling off. We've spoken about
that a lot in terms of mortgages. It's actually also true within corporate lending and I suspect probably
also industry wide. So as you go forward from here, you're going to see a closer correlation between
volume and income growth. So I would say nothing immediate, but logic would suggest Chris that
that's the way that things will go.
But really the sort of roll-off of that higher margin proportion is largely behind us in mortgages. And
then through the early part of 2027, I would expect us to be clear of that in corporate as well.

-- 3 of 17 --

Investor Relations
4
Okay. Kian?
Kian Abouhossein, JP Morgan
Yeah. On fixed income, you clearly highlighted there was nothing unusual happening in fixed income
despite that you underperformed your peers quite significantly. Just trying to understand now that
we've seen all the peers, can you talk a little bit more about sub-segments in fixed income, how do you
rationalise geographically or by sub-segments in terms of business which impacted you. And then
secondly, just on US Consumer, clearly we had the non-NII impact of £20 million that we discussed.
And I just wanted to just see a little bit more how is the US Consumer business performing in light of
the higher rate environment and how we should think about the P&L change in that sense.
Anna Cross
Okay. So we talked about FICC a bit on the day and as you can imagine quite a bit on the road. We do
feel that the underperformance in FICC in the quarter reflects a more difficult market. There are
elements of our mix that would certainly have exacerbated that. So I think most competitors talked
about some pressure in Rates. Rates is a big business for us and one where we feel like there's still
more to go for us to improve our performance there as we've talked about in the past. Equally, there
are parts of the complex where they are either relatively small for us. So Securitised Products is doing
well, but relatively small again. And then there were two or three of our competitors who called out a
pretty good result in Commodities, which clearly is not part of ours either. I think having even adjusted
for that mix, we still feel there's a degree of underperformance there, but certainly the shape of our
business probably meant the result on a mix-adjusted basis was probably a little worse. So more to do
there.
As I look at FICC in Q4, still early in the quarter, I would say it remains quite a difficult environment, but
at the same time, many of the points of positioning that were more difficult for us in terms of the back
end of Q3 have worked their way through. But it’s early in the quarter, still quite a bit to go.
Just moving to non-NII and indeed the US Consumer [Bank] in general, I mean, we called out the
impact of Best Egg and tried to contain that for you by giving you the £20 million number. If I step back
and look at USCB more generally and the way it's performing in the context of high rates in the US,
there's nothing there that surprises us. So we continue to see good ENR formation broadly in
alignment with the industry. So cards growth on an organic basis is up about 6% [YoY].
We do not see any deterioration in credit. Our delinquencies were broadly flat Q on Q. And just to
remind you that American [Airlines] is worth [around] 30bp [on delinquencies]. So had American
[Airlines] remained with us, we would have expected around a 30bp decline across the full quarter. So
really very good there. Nothing [of concern] that we can see. That probably reflects the relatively high
[FICO] that we have across the business as a whole though. So we're not seeing more points of
pressure here than elsewhere.
And then finally, the other thing that we talked about is in a rising rate environment, we tend to see a
timing gap between the pricing of deposits, which price first and then cards which price second. Cards

-- 4 of 17 --

Investor Relations
5
price at the billing date. So it's no more than a month typically between the two. So it's not a big impact
during the rising rate period.
The thing that we're obviously just mindful of is where we started, which is on Best Egg and really what
happens to the APRs across lending products in the US generally and what happens from here. No real
change yet, but very watchful of it.
Michael Christodoulou, Berenberg
Michael from Berenberg, just to continue from USCB higher level, I know you're talking a lot about the
Samsung deal and the opportunity that comes from it. I know you don't really like to talk a lot about
consensus, but what do you think about consensus expectations for the division, if we're thinking
2028 or even maybe further out, do you think we are really capturing the opportunity there or are we
missing something as to how much more could come? And then the next one on the structural hedge.
So we've been talking about deposit competition going up, pricing going up. Is it the right time
arguably to increase the notional in October or is it something more that we're not seeing? Thank you.
Anna Cross
Okay. So let me just talk about USCB. I'm not going to talk about consensus, but let me help you think
about how we think about this business. So it is a consumer bank, not a cards business. As we look at
it, what we've been able to do is start with a very strong partner cards business, which is now more
than 20 years old. It's growing very nicely. We continue to attract new partners. We've then added to
that a digital deposit capability which has grown meaningfully over the last few years. And we've been
able to grow deposits with some of our partners, notably AARP.
And now we have this digital capability in terms of unsecured lending. The opportunity really is for us
to bring this together for our partners in a holistic way. The first one of those is Samsung. So we clearly
have the card now. What you're going to see as we go into 2027 is the other products being added into
there. And that will then give us a greater idea about how these things can work meaningfully better
together. But we have the opportunity to not only expose our other partners to some of that
technology, but the full suite of products.
And then on the structural hedge, when we consider the structural hedge, we are looking for rate
insensitive balances. So by definition, we are excluding anything which we believe will be tempted
away by the deposit competition that we are looking at. So term deposits, we're excluding a large
proportion of the sight deposits. We're excluding a proportion of the current accounts also. And we
are looking at the movement and the changes in those accounts at very, very granular levels and
making decisions on a monthly basis. So if we take a decision to extend the hedge, then it's by very
close analysis to how those deposits are changing over time and what we think the behavioral life of
those deposits is. So it's not a direct reaction to how competitive we think the market is. Thank you.
Jonathan?

-- 5 of 17 --

Investor Relations
6
Jonathan Pierce, Jefferies
Hello. Jonathan Pierce, two as well. First one, just on investment spend a little further out, if I look at
your bridge back at the full year stage, the expectation was investment spend in 2028 would be about
£400 million higher than 2025, excluding Best Egg, which was wrapped into that at the time. But
looking at the bridge now, we're already £600 million ahead in 2027. So if I was to attempt to
extrapolate the bridge into 2028, which I know you don't want to be too drawn on, is it right that the
investment piece would actually be going backwards a little bit? It seems consistent with the
comments you made earlier about front loading some of the investment spend. So would that £400
million increase next year actually be a £200 million negative in 2028? That'd be quite helpful. Next to
the neutral run the bank costs, we can start to get confidence in mid £18 [billion] costs up to 2028.
The second question is on the deposit margin in the UK. There seems to be a bit of a difference in view
out there amongst some of your peers as to what's really driving this move out of sight deposits since
February or March, and in turn lifting the marginal cost of funding. How do you see it? Do you think this
is deposit competition or is it a behavioural response to the big move up in one year swap rates and
then in one year term rates since February? Obviously the former would be a bit more structural,
maybe something to worry about. The latter always tends to be transitory reallocation of portfolio. So
how are you seeing the market?
Anna Cross
Okay. So you were right to pick up on what I said before about front loading of investments. I wouldn't
go as far as to say I would expect them to go negative, but we have definitely pulled forward
investment spend that would otherwise have been stepping up more gradually. The other thing I
would sort of modify slightly in your comments, Jonathan, would be we said that we expected the run
the bank cost to be neutral to [lower]. So clearly that is our objective here to drive operating leverage.
I'm not going to commit as to what that number will be in 2028, but if you think about those two things
separately, we've pulled forward investment and think of our intent here in terms of running the bank
costs to drive that as effectively as we can by essentially driving gross efficiencies and reducing the
marginal cost of growing the bank. That's really what we're trying to do in order to get to the right
shape, not only in 2027, but thereafter. That's a formula you should think about.
On the deposit market, we have a view, appreciate not everyone agrees, that we do think it is a funding
driven matter. That's what we have observed. And we've observed that sort of through 2026 and it's
coincidental with increased issuance of covered bonds. So from that perspective, we anticipated it.
We are broadly in the middle of our range in terms of BUK and that range was driven by the anticipated
change in deposit competition. And we expect that to somewhat continue.
Amit Goel, Mediobanca
Thank you. It's Amit Goel from Mediobanca. I've got two questions. One follows up a little bit on what
Jonathan was asking on cost and one on FICC and revenues for Q4, maybe following up a little bit on
what Kian was asking. So on the cost point, I guess when I look at the slides, I look at the bridge that
was presented in February, it kind of pointed to a cost number of around £18.2 [billion] in 2028. And
now the slides this quarter showing £18.4 [billion] for 2027. So just in terms of understanding that gap,

-- 6 of 17 --

Investor Relations
7
is that kind of business growth and performance pay and investment brought forward or is there other
underlying inflation to think about? And then also within that, when we do that bridge to 2028, I think
previously you suggested there was a greater than £2 billion target for efficiency saves and we're
already by the end of 2027 at £1.9 [billion] or greater than £1.9 [billion] level. So are we expecting
materially more efficiency saves to get that cost to be kind of flat to down? So that's on the cost piece.
And then on the FICC point and into Q4 and basically full year revenue expectations in terms of the
£31.5 billion, if I take what you just said about the FICC environment that you're seeing so far in the
quarter, it looks like you do need the material step up or improvement in FICC in Q4 to get to £31.5
[billion]. So I'm just kind of curious how confident or comfortable you are that you will achieve and/or
beat that level of revenue.
Anna Cross
Okay. Let me take them in turn. So just to orientate everybody, I mean, if we look at page 9, what
we've done is we've given you a fairly broad bucket of costs which is business growth and inflation. So
think of that as the marginal cost of business growth. Think of it as any kind of inflationary pressure.
Performance costs would be in the former. It also includes what we would call BAU investment. So re-
platforming the BUK app would be in that bucket, not in investments. Because in investments, what
we're really focused on is things that will materially change the RoTE of the Group in the future. That's
why we separate them out. Everything else may be investments, but it's a cost of doing business for
the existing business that we have. So it contains a lot of activity related to that, which is why it's a
sizable number in any year.
I'm just going to repeat what I said to Jonathan and in my opening remarks, we expect modest cost
growth from 2025 to 2028. You should think about how we have somewhat accelerated the
investments we talked about and that to the extent that we need to create a specific absolute cost
shape, then we will be focused on the business growth part of it or the running the bank part of it in
order to modify the number. That is quite different from where we've been as a firm historically. We
would have pulled back on investments. That's what we're saying we're not doing here. We believe we
have the confidence and the mechanisms to drive the running the bank costs lower to create the room
for investments. So that's how we intend to manage it. But I'll just remind you that the firm guidance
that we've given you for 2028 is actually in the cost income ratio, for that to be low 50s in 2028.
That is our north star, will remain our north star. What we try to do is give you an absolute number for
2027 to help with the moving parts given the additional SCAs. Just on your second question in relation
to FICC, we talked about this again on the day. There are several factors that create that year on year
step up in income that we expect in the fourth quarter.
NII clearly has considerable momentum across the Group, has been running around £200 million
higher quarter on quarter for every quarter this year. We would expect that to continue and you get
that from our NII guidance. We also have Financing momentum that we would expect to continue.
Those two things are clearly more certain than capital markets activity. Then we come to capital
markets. We have a very clear M&A pipeline, which is up year on year and gives us confidence. And
clearly there's greater line of sight in M&A than there is elsewhere in banking. We have a good ECM
pipeline, but it depends which deals complete. And because of the volatility in the market, there is a

-- 7 of 17 --

Investor Relations
8
degree of timing around that. And then finally it takes me to Markets. If you look at the environment
right now, and I'm going to stress that we are early in the quarter, it's conducive for Equities, probably
less conducive for FICC, but I'd just remind you what I said earlier, which is there are many aspects
around our positioning in FICC in the second half of Q3 that are no longer the case in Q4.
Marina Shchukina, Group Chief of Staff
If I can just add one thing on your point on the gross efficiency savings. We have given you the
disclosure on page 10 in terms of the efficiencies that we've been driving. And you're absolutely right,
we did call out the expectations for greater than £2 billion of gross efficiency savings across the three
years.
Alvaro Serrano, Morgan Stanley
Question one is a clarification. I think you said at the beginning you're comfortable with the NII
consensus in terms of 2027 and 2028. Should we think about that as maybe, the UK is less good, but
this is compensated by the other [businesses]? Did you mean to say that things are broadly going
according to plan? What I'm thinking is there a question mark for US Consumer Bank given the higher
rates?
And second, it's kind of follow up to the theme of the quarter around LCR. Over the next 12, 18
months, your LCR will be down to the level where you probably need to think about it. And if you're
approaching that level presumably 130 or 140, whatever the level is, how do you think about the
management actions available to you as CFO?, Would you think about deposit growth if that's
possible? It might be more affordable than issuing more wholesale. Would you look at repricing the
loans to slow down growth because of the marginal NII contribution? How would you think about it?
Anna Cross
Okay. So let me just clarify what I said. So I said the emerging consensus for 2027, I did not say 2027
and 2028. I said Group and the UK NII are fine. So that's the clarification. We've not made any
comments on 2028 and specifically on the US Consumer Bank. I mean there we've been a bit more
focused on total income overall, just because of the complexity that Best Egg brings in. But just to sort
of reassure, as I said before, the growth in ENR is where we would have expected it to be. It's in
alignment with the market at around 6%. You can see the strength in NIM and you will also recall that I
just spoke about the impact of rising rates in US cards in that we're able to sort of adjust the pricing
within a short period of time. So no specific concerns there.
In terms of the UK funding cost question and at what point do you feel that you have to sort of reassess
your lending? I mean, the way we think about it is we price our lending from the marginal wholesale
cost of funding anyway. And that is what I would have expected most UK banks to do. That's how funds
transfer pricing works. So within the UK bank, they are not pricing to a blended deposit rate. They're
pricing to a funds transfer pricing curve. That's the structure that we have in place now and we would
expect to continue that. So the increase in deposit pricing does not necessarily have an impact on that
pricing right now. Does that make sense? Because that's not how we're pricing the assets now.

-- 8 of 17 --

Investor Relations
9
That said, clearly as your funding optimal point becomes closer, you have to then think about how
you're going to progress from here. And the answer is everything that you described below. But
deposits is not just about term deposits. So you can see that we are growing particularly with our
Premier customers in current accounts. That's really important to us. The health of the deposit
franchise overall is something that we are very focused on. Then we have in the past, or we certainly
have the capability within BUK to issue covered bonds. Clearly it's not something that we've done
immediately, but it's something that we could consider in the future.
And then thirdly, thinking about the mix of your growth, so which products meet hurdle, which don't,
there will always be a range in any environment. But again, that discipline is no different now than I
would expect it to be in six months, 12 months, a year, whenever that optimal point is reached.
The answer is similar if you were to look to the other side of the business. So clearly BUK is within the
ring-fence. It has its own ring-fence liquidity, but the discipline and the actions are no different over in
the [UK] Corporate Bank. So if you look at the BBPLC LCR, it's slightly lower, but not meaningfully so,
because BUK and the Group are broadly in alignment with one another. You can see the strength of
the deposit franchise in UKCB. And again, it prices to a wholesale cost of funds, which is specific to
that legal entity. So it would be higher than in BUK.
Chris Cant, Autonomous
It's Chris from Autonomous. One on corporate spreads please and then a couple of really geeky ones.
So you mentioned corporate spread pressure washing through in the second half or first half of next
year. One of your domestic peers indicated a protracted period of pressure there. They have a back
book spread of something north of 1%. Is there just a level difference here in terms of how you're
thinking about spread pressure washing through on corporate loans versus that particular peer?
Because that seems to have been quite a negative impact for them in terms of consensus thinking on
the NII projection.
And on the geeky ones, you mentioned a DTA write-up. I just wanted to understand how that works.
Are you assuming you're basically offsetting the roughly £100 million directly next year or is that write-
up assuming that the surcharge level is persistent through time? So are you assuming it doesn't last
[long] basically to get £75 million write-up because it seems quite large in proportion.
And on cash flow hedge reserve, you had previously indicated that it would pull to par relatively quickly.
Obviously it's ballooned massively over the last nine months and the move in Q3 in particular was
certainly bigger than I was expecting. Are you still expecting that to pull to par by 2028? I don't see how
on current swap projections you get anywhere close when it comes to that. Obviously it has an impact
on RoTE delivery because it helps reduce TNAV. So just how you're thinking about that.
Anna Cross
So the point on corporate spreads may have something to do with the relative size of [the] back book.
Remember this is a market which we perhaps said that we have been somewhat constrained in. So we
have not been as active in the past and therefore any back book roll-off is by definition going to be

-- 9 of 17 --

Investor Relations
10
smaller, whereas we're now leaning into that business. So that's the only explanation I can give you
about that relativity Chris.
On DTAs, we are not assuming that it stays for more than 15 months.
And then finally on the cash flow hedge reserve, I mean you're absolutely right. We've been assuming
that this thing was pulled to par in 2028. Clearly it's gone in the opposite direction because of where
the curve has gone. So it's going to take a longer time. It's difficult for us to determine exactly when.
We will come back to you on the absolute impact of the cash flow hedge reserve in terms of pence on
TNAV. But clearly what it's doing is it's suppressing the TNAV, it's flattering the RoTE, but it has no
impact on regulatory capital or our ability to distribute. It kind of is what it is. What we're focused on is
the things that we can control, which are the [attributable profit] we generate.
Chris Cant
In terms of rolling together with the regulatory capital, obviously you haven't baked into your capital
planning the Pillar 2A reduction, which we now know. So combined, I mean when you've given the RoTE
[targets in the] last two strategic planning cycles, you've had something there for headwind from cash
flow hedge reserve, which was quite meaningful. The combination of presumably marking to market
on the capital target at some point and this cash flow hedge, that's going to be quite meaningful on
your RoTE target presumably. Is that something that you'll be updating at some point before we get
through to 2028?
Anna Cross
So what we said is that we will come back to you at the full year to talk to you about how we are
considering where in the range we will operate. In terms of the cash flow hedge reserve, I'm not going
to make predictions about where that's going to go. I just remind you that our RoTE targets are
uncapped.
Marina Shchukina
And we have included on page 52, just a little call out to remind you guys when you're doing your
modelling, the 25bp movement in rates is about £1.2 billion [on the cash flow] hedge reserve, just so
you're not forgetting.
Andrew Dickens, Interim Group Treasurer
Just to help you understand, the cash flow hedge reserve is driven by the net of our structural hedge
and some of our mortgage hedging. So you can work out roughly what the rate sensitivity of the
structural hedge is across product structural hedge. Mortgages we don't disclose. There's a net
receive position in rates, which is a result of the structural hedge. So it will just play through over time
based on where rates go. There is obviously an accrual factor, so that bleeds back over time as well,
but that's the driver of the underlying rate exposure.

-- 10 of 17 --

Investor Relations
11
Ben Toms, RBC
[We've] just had a Budget, where the big decisions have been deferred. I think Barclays had a survey
out yesterday which pointed to an expectation that corporates are ready to increase their spending
post-Budget. How are you thinking about any change in momentum of corporate loan growth post-
Budget? And given your strong liquidity talked about already, would you expect to grow faster than
the system in respect of corporate lending?
And then secondly, you guided at Q3 that you would offer motor finance customers early assessment
in some cases. Where are you drawing the line on where to make offers? Is it a Johnson type case or is
there kind of a broader view there? And if the objective is to remove noise and protect downside risk,
why not just offer everybody who is due payment under the existing scheme early assessment? Thank
you.
Anna Cross
Okay. So Ben, what you're referring to is the sort of corporate sentiment review that we do. What we
noted pre-Budget was an expected increase in demand for lending post-Budget when people saw the
clarity and clearly that's what's now coming through. We feel really well positioned to pick that up both
because of the breadth of our deposit platform in the UK. So we gave you new disclosure that showed
you [on Page 28] what our deposit franchise looks like in the UK. It's very, very broad going obviously
from SMEs in the UK all the way through to International Corporate Bank clients in the IB. And we've
never brought that together before. So we are the largest deposit taker of corporates in the UK, but
we have the lowest loan to deposit ratio. So we feel like we are positioned very well with those clients
in order to facilitate that demand. We've been growing faster than the system anyway, and there's no
reason why that shouldn't remain the case. That would certainly be our intention.
On your second point on Motor Finance, our objective is to, for the cases which we believe are aligned
to something like Johnson, is to put those behind us as quickly as possible. That is our objective. This
is a market that we are no longer in. We have a low market share. We want to get that cash in the hands
of consumers as soon as possible and therefore we have defined the population before the final
settlement and they are the ones that we will be reaching out to. Nothing really more complex than
that around it.
Andrew Coombs, Citi
Just two follow ups. First is going back to US Consumer Bank. Previously, when adjusting for American
Airlines and Best Egg, you gave us some guidance on the split of revenues between NII and non-NII
income. Since then, we've obviously seen a few changes in the market, changes in securitisation, and
costs. And actually, if we look at Q3 specifically, I mean the split of revenues is almost identical to a
year ago, admittedly with the one off in NII, but I don't know if you could just give us some forward
guidance of where you see the revenue split between NII and non-NII in the US Consumer Bank. Still
the same as what you said previously, or you have slightly different expectations now.
Secondly, on the UK corporate deposit franchise, you've highlighted your loan to deposit ratio 29%
overall, 38% on UKCB. You clearly don't need to be aggressive in deposit gathering to fund the loan

-- 11 of 17 --

Investor Relations
12
growth subject to LCR, which we can debate. And yet when you look at your deposit base in UK
Corporate [Bank], all of the growth in the last two years is in term, up until this quarter where we're
actually seeing a slight contraction in deposits. So is there any change in strategy on UK corporate
book? Is it a case of, hey, we're not going to pay up for deposits anymore, we don't need to do so.
Anna Cross
So what we've done is we've given you some broad guidance on total income for US Consumer Bank
and the exact split and the timing of the split, has been more difficult to determine as we've gone
through this transition period. But essentially what we said was we would expect to build back to
around Q1 total levels by Q4 with a different mix therein. But just noting that AA had a fairly high
proportion of non-NII because it was a transactor book.
So, I think that's one of the things that perhaps has caught people a little bit by surprise in that the loss
of income from AA was disproportionately non-NII versus perhaps expectations of that. The
modification that we've given you now is that we've told you that there is a roughly £20 million per
quarter headwind in Best Egg from these sold securitisation prices to the exterior. That's the only
change that we have made to the income guidance that we've given you on USCB.
And then just in terms of corporate lending, there has been no change in strategy. You're just seeing
us react and move in alignment with the industry more generally. I would just call out that clearly UKCB
sits within BBPLC, so the non-ring-fenced bank, which for us is a very large and diverse group with
multiple sources and uses of funding.
Robert Noble, Deutsche Bank
Just two questions please. One on the dividends. So, you've had an absolute dividend guide for a few
years now. Would you consider moving to a payout ratio? What state does the Group need to be in for
you to consider changing that to be a payout ratio similar to other UK banks?
And then just on rates, is there a point where the swap curve gets to where you think it's negative for
the Group? And so, we've seen rates come down 25bp in the last couple of weeks. Do you see that as
a good thing or a bad thing for your business?
Anna Cross
Yeah. Okay. So on dividends, you're right. We moved from £1.2 billion to £2 billion plans for the current
year. Our preference has been for an absolute guide for distributions. I guess given the proportion that
we have of buybacks within that mix really and reflecting the fact that we have a fundamentally
different business mix and frankly a UK-US business. So, as we're talking to people on the other side
of the Atlantic, they're going to have a different perspective of this, Rob. So, we're happy with what
we've guided to so far. What we said in February was that we would continue to keep the dividend
under review, but at this point in time our preference is for buybacks and our preference is for giving a
sort of absolute or greater than absolute guidance for the total distributions.
In terms of the swap curve, whether that be up or down, there's no magic rate here. There's clearly
benefits that come through higher rates, for example, in the structural hedge. There are clearly

-- 12 of 17 --

Investor Relations
13
benefits that come through higher rates, for example, in the way some of the Investment Bank
businesses work. But equally, if rates got too high, then we might have some concerns around
affordability led impairments, whether that be in corporates or in consumers. We're a long way from
any of that right now. For us, what we would need to see would be meaningfully higher rates then
feeding into unemployment, for example, for us to be concerned that rates were too high. We don't
yet see that. So, at this point in time, I would say there's no Goldilocks rate, if that's what you're looking
for, either up or down. Given the multiple effects that you see through the P&L, very difficult to give
you straight answer.
Mathias Peters, Barclays Investor Relations
Again, probably worth mentioning our introductory comments that we think NII has not peaked in
2026.
Seamus Murphy, Carraighill
I was just looking at your comments on the structural hedge in the UK. And I think you said £195 billion
[Q326 UK retail] deposits, I think, and I was just working out the numbers. I think [c.]70% [of the hedge]
is allocated to the UK business. But if I work it out and I take off the current accounts as 100% hedged,
then I work out 80% of the sight deposits are hedged. So I just wonder, that means that you're very,
very hedged on your savings accounts, which is about 80%, which seems exceptionally high in the
context of all the other European UK banks, if my thinking is correct. But in the contrary to that, your
UK corporate business basically has only got a tiny hedge, but it's got £94 billion of current accounts.
So I'm just trying to understand what is differential in terms of your modelling on that side. That's
question number one.
I suppose the second question, which is kind of a different question in some sense, and I know it was
asked on the Q3 call about your share price, because when we look at obviously Barclays, the share
price is obviously, I don't want to say languishing, but certainly it's trading cheaper than its peers. And
I was trying to think about why that might be the case. But then when I was looking at your business
like relative to Lloyds or NatWest or your US franchise, I suppose one could argue that you're subscale
in most markets that you operate in. And I'm just wondering; do you think that's a fair assessment in
terms of why your share price may be trading and whether scale matters in banking? And coming back
to the discussions you may have at the Board level or otherwise amongst the executives in the context
of you can't consolidate your way out of this mature stock where it is.
And the idea that Barclays is a target basically in that context or whether you would put yourselves up
for sale.
Anna Cross
So just starting with the structural hedge, but I'm not going to make any comments on specific
product mixes, but we don't hedge all the current accounts. As I said before, we are looking for the
elements of any deposit portfolio which is rate insensitive. So, there would be a large proportion
potentially of sight deposits which is in that category. I'll also remind you that with different types of
products, we do hedge across different tenors. So, to the extent that we have very, very good line of

-- 13 of 17 --

Investor Relations
14
sight to a length of relationship, we would typically have an element of that hedge which is on a longer,
let's say seven-year tenor, whereas we might have some that's shorter. So, it's the construct within
the hedge as well. Andrew, anything you would want to add?
Andrew Dickens, Interim Group Treasurer
I think that's the key point. I mean obviously this is an income allocation, the notional allocation that
we've disclosed. There's an element obviously of equity there and as Anna said, I think the tenor mix,
we've disclosed an average weighted average life, but that is a broad range of tenors. And so there's
no one-size-fits-all hedge.
Anna Cross
Yeah. And I think it's an important distinction here. Remember the equity structural hedge at the same
time is clearly driving an increased level of income into all of the businesses. And that's why you see
this changing skew towards the IB.
To your second question, look, as ever, I'm going to say the share price is an output. It's an output of
the consistency of results that we deliver, and that is our objective here. When we started off at the
beginning of 2024, we had three main targets. They were to have a RoTE that was greater than 12%,
to move the Investment Bank RWAs down through holding the Investment Bank [RWAs] flat and
growing the UK and to distribute at least £10 billion. Now the Investment Bank RWAs percentage is
going to be a little different because of the timing of IRB, but we have held the Investment Bank [RWAs]
flat and you can see we're at £28 billion RWA deployment at the end of the third quarter.
So all of the targets that we have set out, we feel like we are delivering, but it's only three years. And
actually our view is that Barclays needs to continue to generate not only high returns, but returns
which are consistently and predictably higher. And that's not a three-year journey. So hopefully the
market will increasingly reward that as it has done over the last three years. To the point that you made
around subscale, I think there's a difference between being the largest in the market and subscale.
So, BUK is not the largest retail and business bank in the UK, but it's by no means subscale. The
Investment Bank is not the largest Investment Bank, but it's by no means subscale in any of the
markets that we choose to compete within. The business where we are clearly subscale is [Private
Bank and Wealth Management] and that's a business that we've chosen to grow organically as
opposed to inorganically. So, we are very clear in our minds about that distinction and where we feel
that there are gaps in our proposition. Clearly, they are the ones that we seek to fill in over time.
Thank you very much folks. Looking forward to seeing you in February, if not in December for drinks.
Thank you.

-- 14 of 17 --

Investor Relations
15
Important Notice
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. The information, statements and
opinions contained in this presentation do not constitute a public ofer under any applicable legislation, an ofer
to sell or solicitation of any ofer to buy any securities or �nancial instruments, or any advice or recommendation
with respect to such securities or other �nancial instruments.
Information relating to:
• 	regulatory capital, leverage, liquidity, resolution and related regimes is based on Barclays' interpretation
of applicable rules and regulations as in force and implemented in the UK as at the reporting date,
including, but not limited to: CRR; the PRA Rulebook; and any applicable delegated acts, implementing
acts or technical standards; in each case as amended and, where applicable, as such rules and
regulations form part of domestic law by virtue of the European Union (Withdrawal) Act 2018. All such
regulatory requirements are subject to change and disclosures made by the Group will be subject to any
resulting changes. The Pillar 2A requirement is also subject to at least annual review;
• 	MREL reported as at 31 December 2025 is based on Barclays' understanding of the Bank of England’s
statement of policy on "The Bank of England's approach to setting a minimum requirement for own
funds and eligible liabilities (MREL)" published in December 2021, and its MREL requirements
communicated to Barclays by the Bank of England. In July 2025, the Bank of England published
amendments to the December 2021 MREL statement of policy, which took efect on 1 January 2026.
Binding future MREL requirements remain subject to change, as determined by the Bank of England,
taking into account a number of factors as described in the amended statement of policy, along with
international developments;
• 	future regulatory capital, leverage, liquidity, funding and/or MREL, including forward-looking
illustrations, are provided for illustrative purposes only and are not forecasts of Barclays’ results of
operations or capital position or otherwise. Illustrations regarding the capital �ight path, end-state
capital evolution and expectations and MREL build are based on certain assumptions applicable at the
date of publication only which cannot be assured and are subject to change.
Non-IFRS performance measures
Barclays’ management believes that the non-International Financial Reporting Standards (“IFRS”) performance
measures included in this presentation provide valuable information to the readers of the �nancial statements as
they enable the reader to identify a more consistent basis for comparing the businesses’ performance between
�nancial periods and provide more detail concerning the elements of performance which the managers of these
businesses are most directly able to in�uence or are relevant for an assessment of the Group. They also re�ect an
important aspect of the way in which operating targets are de�ned and performance is monitored by Barclays’
management. However, any non-IFRS performance measures in this presentation are not a substitute for IFRS
measures and readers should consider the IFRS measures as well. Refer to the appendix of the Barclays PLC
Results Announcements for each of the periods ended 31 March 2021, 31 March 2023, 31 March 2025, 30 June
2025, 30 September 2025, 31 December 2025, and 31 March 2026 and 30 June 2026, and the Group Reporting

-- 15 of 17 --

Investor Relations
16
Changes 2023 Results Resegmentation Document, respectively, which are available at Barclays.com, for further
information and calculations of non-IFRS performance measures included throughout this presentation, and the
most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US
Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with
respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future
performance and that actual results or other �nancial condition or performance measures could difer materially
from those contained in the forward-looking statements. Forward-looking statements can be identi�ed by the
fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words
such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’,
‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also
may be made verbally by directors, o�cers and employees of the Group (including during management
presentations) in connection with this document. Examples of forward-looking statements include, among
others, statements or guidance regarding or relating to the Group’s future �nancial position, business strategy,
income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory
ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected
levels of growth in banking and �nancial markets, industry trends, any commitments and targets (including
sustainability-related commitments and targets), plans and objectives for future operations, IFRS and other
statements that are not historical or current facts. By their nature, forward-looking statements involve risk and
uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as
at the date on which they are made. Forward-looking statements may be afected by a number of factors,
including, without limitation: changes in legislation, regulations, governmental and regulatory policies,
expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other
accounting standards, including practices with regard to the interpretation and application thereof and emerging
and developing sustainability reporting standards (including emissions accounting methodologies); changes in
tax laws and practice; the outcome of current and future legal proceedings and regulatory investigations; the
Group’s ability along with governments and other stakeholders to measure, manage and mitigate the impacts of
climate change efectively or navigate inconsistencies and con�icts in the manner in which climate policy is
implemented in the regions where the Group operates, including as a result of the adoption of rules and
regulations taking a diferent or opposing position on sustainability matters, or other forms of governmental and
regulatory action against sustainability policies; environmental, social and geopolitical risks and incidents and
similar events beyond the Group’s control; �nancial crime; the impact of competition in the banking and �nancial
services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past,
current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including
in�ation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign
exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in
credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes
in consumer behaviour; changes in trade policy, including the imposition of tarifs or other protectionist

-- 16 of 17 --

Investor Relations
17
measures; the direct and indirect consequences of the con�icts in Middle East and Ukraine on European and global
macroeconomic conditions, political stability and �nancial markets; changes in US legislation and policy;
developments in the UK’s relationship with the European Union; the risk of cyberattacks, information or security
breaches, technology failures or operational disruptions and any subsequent impact on the Group’s reputation,
business or operations; the use of new technology, including arti�cial intelligence; the Group’s ability to access
funding; and the success of acquisitions, disposals, joint ventures and other strategic transactions. A number of
these factors are beyond the Group’s control. As a result, the Group’s actual �nancial position, results, �nancial
and non-�nancial metrics or performance measures or its ability to meet commitments and targets may difer
materially from the statements or guidance set forth in the Group’s forward-looking statements. In setting its
targets and outlook for the period 2026-2028, Barclays has made certain assumptions about the macroeconomic
environment, including, without limitation, in�ation, interest and unemployment rates, the diferent markets and
competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs
savings and other structural actions. Additional risks and factors which may impact the Group’s future �nancial
condition and performance are identi�ed in Barclays PLC’s �lings with the US Securities and Exchange
Commission ("SEC") (including, without limitation, Barclays PLC Annual Report’s on Form 20-F for the �nancial
year ended 31 December 2025), which are available on the SEC’s website at www.sec.gov.
Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction
(including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake
no obligation to update publicly or revise any forward-looking statements, whether as a result of new information,
future events or otherwise.

-- 17 of 17 --